GeneCentric Therapeutics (Series B-1)
Funding Details
- Awarder
- Inbox
- Date Award
- November 08, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $7,500,000
Company Info
- Company Description
- GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.
- Market
- Oncology therapeutics
- Location
- Durham, North Carolina, United States
- Coinvestors
- Alexandria Venture Investments, Hatteras Venture Partners, IAG Capital Partners, LabCorp